Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: A single center experience

Medical Oncology

Volumn 26, Issue 4, 2009, Pages 386-392

  Eren, Orhan Onder ^a   Artac, Mehmet ^a   Boruban, Melih Cem ^a   Yavas, Ozlem ^a   Arslan, Ugur ^a   Basaranoglu, Metin ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Cancer; Cytotoxic chemotherapy; Hepatitis B; Lamivudine; Reactivation

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; METHOTREXATE; OXALIPLATIN; PREDNISOLONE; RITUXIMAB; TRASTUZUMAB; VINCRISTINE;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CHORIOCARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; LUNG CANCER; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RECTUM CANCER; SIDE EFFECT; STOMACH CANCER; TREATMENT OUTCOME; VIRUS REACTIVATION;

ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRUS ACTIVATION;

EID: 70949086791     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9133-4     Document Type: Article

References (34)

1. WM Lee 1997 Hepatitis B virus infection N Engl J Med 337 24 1733 45 10.1056/NEJM199712113372406 10.1056/NEJM199712113372406 1:STN:280: DyaK1c%2FktFyjtA%3D%3D 9392700 (Pubitemid 27527771)
2. G Lalazar D Rund D Shouval 2007 Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies Br J Haematol 136 5 699 712 10.1111/j.1365-2141.2006.06465.x 10.1111/j.1365-2141. 2006.06465.x 1:CAS:528:DC%2BD2sXjvFWmtb0%3D 17338776 (Pubitemid 46246304)
3. W Yeo PK Chan S Zhong, et al. 2000 Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors J Med Virol 62 3 299 307 10.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0 10.1002/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0 1:CAS:528:DC%2BD3cXns1Ols7c%3D 11055239 (Pubitemid 30740118)
4. AS Lok RH Liang EK Chiu KL Wong TK Chan D Todd D Todd 1991 Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study Gastroenterology 100 1 182 8 1:STN:280: DyaK3M%2FmtVSiuw%3D%3D 1983820
5. K Kumagai T Takagi S Nakamura, et al. 1997 Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan Ann Oncol 8 Suppl 1 107 9 10.1023/A:1008234807768 10.1023/A:1008234807768 9187442
6. W Yeo PK Chan P Hui, et al. 2003 Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study J Med Virol 70 4 553 61 10.1002/jmv.10430 10.1002/jmv.10430 12794717 (Pubitemid 36734719)
7. MS Dai PF Wu RY Shyu JJ Lu TY Chao 2004 Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration Liver Int 246 540 6 10.1111/j.1478-3231. 2004.0964.x (Pubitemid 40028604)
8. JS Lubel AG Testro PW Angus 2007 Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management Intern Med J 37 10 705 12 1:STN:280:DC%2BD2srntlCjsg%3D%3D 17894766
9. CG Alexopoulos M Vaslamatzis G Hatzidimitriou 1999 Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours Br J Cancer 81 1 69 74 10.1038/sj.bjc.6690652 10.1038/sj.bjc.6690652 1:CAS:528:DyaK1MXmt12htrs%3D 10487614 (Pubitemid 29415493)
10. W Yeo PJ Johnson 2006 Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy Hepatology 43 2 209 20 10.1002/hep.21051 10.1002/hep.21051 1:CAS:528:DC%2BD28XhvVSgu7o%3D 16440366 (Pubitemid 43303989)
11. SJ Leaw CJ Yen WT Huang TY Chen WC Su CJ Tsao 2004 Preemptive use of interferon or lamivudine for hepatitis B reactivation inpatients with aggressive lymphoma receiving chemotherapy Ann Hematol 83 5 270 5 10.1007/s00277-003-0825- 8 10.1007/s00277-003-0825-8 1:CAS:528:DC%2BD2cXivVCltLk%3D 15060745 (Pubitemid 38594322)
12. W Yeo EP Hui AT Chan, et al. 2005 Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine Am J Clin Oncol 28 4 379 84 10.1097/01.coc.0000159554.97885.88 10.1097/01.coc.0000159554. 97885.88 16062080 (Pubitemid 41099543)
13. FL Clark MW Drummond S Chambers BA Chapman WN Patton 1998 Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma Ann Oncol 9 4 385 7 10.1023/A:1008206519571 10.1023/A:1008206519571 1:STN:280: DyaK1czgtVCmtQ%3D%3D 9636828 (Pubitemid 28273030)
14. W Yeo B Zee S Zhong, et al. 2004 Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy Br J Cancer 90 7 1306 11 10.1038/sj.bjc. 6601699 10.1038/sj.bjc.6601699 1:CAS:528:DC%2BD2cXis1aitL0%3D 15054446 (Pubitemid 38586252)
15. CH Hsu HC Hsu HL Chen, et al. 2004 Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy Anticancer Res 24 5A 3035 40 1:CAS:528:DC%2BD2cXhtVSjsLnN 15517913
16. R Tur-Kaspa RD Burk Y Shaul DA Shafritz 1986 Hepatitis B virus DNA contains a glucocorticoid-responsive element Proc Natl Acad Sci USA 83 6 1627 31 10.1073/pnas.83.6.1627 10.1073/pnas.83.6.1627 1:CAS:528:DyaL28XitVWgs7o%3D 3006059
17. GK Lau HH Yiu DY Fong, et al. 2003 Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy Gastroenterology 125 6 1742 9 10.1053/j.gastro.2003.09.026 10.1053/j.gastro. 2003.09.026 1:CAS:528:DC%2BD2cXhtVOruw%3D%3D 14724827 (Pubitemid 37500439)
18. RG Gish S Locarnini 2004 Studying the treatment of chronic hepatitis B viral infection in special populations Methods Mol Med 96 465 98 1:CAS:528:DC%2BD2cXitlahs7Y%3D 14762288
19. RP Perrillo 2001 Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease Gastroenterology 120 4 1009 22 10.1053/gast.2001.22461 10.1053/gast.2001.22461 1:CAS:528:DC%2BD3MXitlertLk%3D 11231956
20. Y Nakamura T Motokura A Fujita T Yamashita E Ogata 1996 Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991 Cancer 78 10 2210 5 10.1002/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0 10.1002/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0 1:STN:280:DyaK2s%2Fns1SqsQ%3D%3D 8918416 (Pubitemid 26367616)
21. AL Cheng CA Hsiung IJ Su, et al. 2003 Lymphoma Committee of Taiwan Cooperative Oncology Group. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma Hepatology 37 6 1320 8 10.1053/jhep.2003.50220 10.1053/jhep.2003.50220 1:CAS:528: DC%2BD3sXkvFWltb4%3D 12774010 (Pubitemid 36667311)
22. E Gurol C Saban O Oral A Cigdem A Armagan 2006 Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey Eur J Epidemiol 21 4 299 305 10.1007/s10654-006-0001-2 10.1007/s10654-006-0001-2 16685581 (Pubitemid 43732302)
23. R Liang GK Lau YL Kwong 1999 Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem J Clin Oncol 17 1 394 8 1:STN:280:DyaK1MzosFCnsg%3D%3D 10458258
24. W Yeo PK Chan HL Chan FK Mo PJ Johnson 2001 Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis J Med Virol 65 3 473 7 10.1002/jmv.2060 10.1002/jmv.2060 1:STN:280:DC%2BD3MrkvFSrsw%3D%3D 11596081 (Pubitemid 32959072)
25. A Goldhirsch JH Glick RD Gelber AS Coates B Thürlimann HJ Senn 2005 Panel members. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 Ann Oncol 16 10 1569 83 10.1093/annonc/mdi326 10.1093/annonc/mdi326 1:STN:280:DC%2BD2MvpvFKhsA%3D%3D 16148022 (Pubitemid 41511089)
26. AK Conlin AD Seidman 2007 Taxanes in breast cancer: an update Curr Oncol Rep 9 1 22 30 10.1007/BF02951422 10.1007/BF02951422 1:CAS:528: DC%2BD2sXpt1Grur4%3D 17164044
27. MS Dai PF Wu JJ Lu RY Shyu TY Chao 2004 Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study Support Care Cancer 12 3 191 6 10.1007/s00520-003-0549-2 10.1007/s00520-003-0549-2 15074316 (Pubitemid 38374680)
28. JC Cheng MC Liu SY Tsai WT Fang J Jer-Min Jian JL Sung 2004 Unexpectedly frequent hepatitis B reactivation by chemoradiation in postgastrectomy patients Cancer 101 9 2126 33 10.1002/cncr.20591 10.1002/cncr.20591 15389480 (Pubitemid 39425390)
29. JS Macdonald SR Smalley J Benedetti 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 10 725 30 10.1056/NEJMoa010187 10.1056/NEJMoa010187 1:STN:280:DC%2BD3Mvps1Cqug%3D%3D 11547741 (Pubitemid 34936653)
30. G Rossi A Pelizzari M Motta M Puoti 2001 Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy Br J Haematol 115 1 58 62 10.1046/j.1365-2141.2001.03099.x 10.1046/j.1365-2141.2001.03099.x 1:CAS:528:DC%2BD3MXotFWmsLw%3D 11722410 (Pubitemid 32995093)
31. ND Simpson PW Simpson AM Ahmed, et al. 2003 Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with lamivudine J Clin Gastroenterol 37 1 68 71 10.1097/00004836-200307000-00017 10.1097/00004836-200307000-00017 1:CAS:528:DC%2BD3sXks1yqtr4%3D 12811213 (Pubitemid 36734337)
32. R Idilman 2006 Duration of lamivudine prophylaxis in inactive hepatitis B virus carriers with haemato/oncological malignancies who receive chemotherapy Gut 55 8 1208 9 1:STN:280:DC%2BD28vis12isA%3D%3D 16849352
33. LH Katz A Fraser A Gafter-Gvili L Leibovici R Tur-Kaspa 2008 Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis J Viral Hepat 15 2 89 102 1:STN:280:DC%2BD1c%2Fit1ahtg%3D%3D 18184191
34. R Loomba A Rowley R Wesley TJ Liang JH Hoofnagle F Pucino, et al. 2008 Systematic review: the effect of preventive lamivudine on hepatitis reactivation during chemotherapy Ann Intern Med 148 7 519 28 18378948